Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin and CBT in Autism Spectrum Disorder
NCT01914939Phase 2Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Apr 2014
- Primary completion
- Nov 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of oxytocin in Autism Spectrum Disorder (ASD), sponsored by Massachusetts General Hospital. Started Apr 2014; status: completed.
02
Drugs
oxytocin
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01914939.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01914939.